The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines, published in the journal Blood Advances, were developed following a rigorous review process and aim to improve and accelerate diagnosis for individuals living with the disorder.
This article was originally published on MedicalXpress.com

